Pfiz­er tar­get­ed by ac­tivist, fol­low­ing post-pan­dem­ic stum­bles — re­ports

The ac­tivist in­vestor Star­board Val­ue has tak­en a stake in Pfiz­er, ac­cord­ing to me­dia re­ports, fol­low­ing the drug­mak­er’s months of lack­lus­ter re­sults as it came …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER